About us 

MEDISTICK-IT Ltd.

Concept to Production.

Discover how the initial concept was born, the difficulties of progressing through the stages of innovation and manufacturing during the most adverse times for business and medical application production.

From MEDISTICK-IT base in Liverpool to prototype development in Shenzhen ‘China’, the journey was over complexed between Pandemic extremities of trade and the red or green light of travel however, in the face of adversity the MEDISTICK-IT team pushed through all barriers alongside our collaborators to get the project to manufacturing status in October 2021.

JANUARY 2019

CONCEPT

The core product original conceptual creation born from established hair control systems across multi discipline trading platforms in commercial and retail settings.

 

 

FEBRUARY 2019

DIT & CHINA

Liaising with the DTI & China and UK Department for International Trade China, MEDISTCK-IT was able to produce exact CAD drawings for manufacturing prototypes and submission for intellectual property registration.

JANUARY 2019

CONCEPT

The core product original conceptual creation born from established hair control systems across multi discipline trading platforms in commercial and retail settings.

 

 

FEBRUARY 2019

DIT & CHINA

Liaising with the DTI & China and UK Department for International Trade China, MEDISTCK-IT was able to produce exact CAD drawings for manufacturing prototypes and submission for intellectual property registration.

APRIL 2019

IP FINE DETAIL

Intellectual property rights was important from the early stages of development and this process took precedence over every other aspect of design, we are almost at fully granted stage.

Intellectual Property Rights For medical use applied for.

Trademark ‘Pending’.

 

 

APRIL 2019

CE NOTIFIED BODY

CE certification was crucial for supply chain management to ensure all notified body regulatory and quality procedures were monitored and maintained at every stage of development through to manufacturing.

APRIL 2019

IP FINE DETAIL

Intellectual property rights was important from the early stages of development and this process took precedence over every other aspect of design, we are almost at fully granted stage.

Intellectual Property Rights For medical use applied for.

Trademark ‘Pending’.

 

APRIL 2019

CE NOTIFIED BODY

CE certification was crucial for supply chain management to ensure all notified body regulatory and quality procedures were monitored and maintained at every stage of development through to manufacturing.

MAY 2019

ACTIVE MEDICAL SETTINGS

Having a World Class Centre of Excellence such as Alder Hey Children’s Hospital with an internal innovation department so close to MEDISTICK-IT HQ in Liverpool where both teams are driven and share a passion to solving real world healthcare challenges provided a platform of interaction and discovery in active medical settings.

JANUARY 2020

RESEARCH AND DEVELOPEMNT FUNDING

Funding for additional R&D was established with innovation being at the core of MEDISTICK-IT, the products met the eligibility criteria and scope for UK Research and Innovation funding threshold.

MAY 2019

ACTIVE MEDICAL SETTINGS

Having a World Class Centre of Excellence such as Alder Hey Children’s Hospital with an internal innovation department so close to MEDISTICK-IT HQ in Liverpool where both teams are driven and share a passion to solving real world healthcare challenges provided a platform of interaction and discovery in active medical settings.

JANUARY 2020

RESEARCH AND DEVELOPEMNT FUNDING

Funding for additional R&D was established with innovation being at the core of MEDISTICK-IT, the products met the eligibility criteria and scope for UK Research and Innovation funding threshold.

FEBRUARY 2020

NHS INNOVATION AGENCY 

Getting the agency involved was a master stroke to expedite NHS feedback.

They understand the needs of the health systems and are well placed to broker innovative solutions, while collaborating across England to take what works best and quickly spread it nationally, responding to the diverse needs of patients and the population through partnerships and collaboration.

MARCH 2020

NEXUS HELPING US EVALUATE RESEARCH DATA.

Nexus are an established and trusted consultancy who have been working with the NHS, NICE, the pharmaceutical industry, clinical trials units and international research funding bodies for almost a decade. Their involvement allowed us to get to grips with our research question faster.

FEBRUARY 2020

NHS INNOVATION AGENCY 

Getting the agency involved was a master stroke to expedite NHS feedback.

They understand the needs of the health systems and are well placed to broker innovative solutions, while collaborating across England to take what works best and quickly spread it nationally, responding to the diverse needs of patients and the population through partnerships and collaboration.

MARCH 2020

NEXUS HELPING US EVALUATE RESEARCH DATA.

Nexus are an established and trusted consultancy who have been working with the NHS, NICE, the pharmaceutical industry, clinical trials units and international research funding bodies for almost a decade. Their involvement allowed us to get to grips with our research question faster.

MAY 2020

POSITIVE MEDICAL FEEDBACK 

Alder Hey Plastics Team implemented an application review of MEDISTICK-IT products across several potential injury settings, there was resounding positive feedback from across the team. Our approach has always been to offer a new solution to a long-standing issue of hair control and this has provided a innovative and versatile medical device.

JUNE 2020

MHRA CLINICAL MEDICAL TRIALS.

MI-3 supported the product from an early stage and assisted with MHRA Clinical regulatory authorisation application in UK and manufacturing evaluation in China.

 

 

 

 

MAY 2020

POSITIVE MEDICAL FEEDBACK 

Alder Hey Plastics Team implemented an application review of MEDISTICK-IT products across several potential injury settings, there was resounding positive feedback from across the team. Our approach has always been to offer a new solution to a long-standing issue of hair control and this has provided a innovative and versatile medical device.

JUNE 2020

MHRA CLINICAL MEDICAL TRIALS.

MI-3 supported the product from an early stage and assisted with MHRA Clinical regulatory authorisation application in UK and manufacturing evaluation in China.

 

 

 

 

OCTOBER 2020

GLOBAL FUTURE 

International IP

International patent rights for medical use applied for in EU and globally.

International design rights granted and international trade mark granted.

SEPTEMBER 2021

LJMU REAL WORLD TESTING

Liverpool John Moores University Real World Validation undertaken.

Aim of review Real-World Data (RWD) and Real-World Evidence (RWE) are playing an increasing role in health care decisions

 

 

 

 

OCTOBER 2020

GLOBAL FUTURE 

International IP

International patent rights for medical use applied for in EU and globally.

International design rights granted and international trade mark granted.

SEPTEMBER 2021

LJMU REAL WORLD TESTING

Liverpool John Moores University Real World Validation undertaken.

Aim of review Real-World Data (RWD) and Real-World Evidence (RWE) are playing an increasing role in health care decisions

 

Global approach to to Design & Manufacturing.

Making the right choice of manufacturer early in the development process has been a significant link in the process of getting MEDISTICK-IT ready for product launch. Medistickit has established important manufacturing relationships in Shenzhen ‘China’.

Global approach to to Design & Manufacturing.

Making the right choice of manufacturer early in the development process has been a significant link in the process of getting MEDISTICK-IT ready for product launch. Medistickit has established important manufacturing relationships in Shenzhen ‘China’.

Manufacturing
error: MEDISTICKIT Ltd